Aspiriant Risk-Managed Equity Allc Adv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares RMEAX
- NAV / 1-Day Return $18.15 / −0.77 %
- Fund Size $1.5B
- Adjusted Expense Ratio 0.950%
- Net Expense Ratio 0.290%
- Fee Level: Distribution Average
- Share Class Type No Load
- Morningstar Category Global Large-Stock Blend
- Equity Style Box (Funds) Large Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 1.40%
- Turnover Ratio 21%
Morningstar’s Analysis RMEAX
Will RMEAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 73.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
GMO Quality VI | 33.79 | 493M | — |
Schwab Fundamental Emerging MarketsEqETF | 7.34 | 107M | — |
RIEF STRATEGIC PARTNERS FUND | 6.96 | 102M | — |
Baillie Gifford Emerging Markets Eqs K | 5.23 | 76M | — |
GMO Equity Dislocation Invmt A USD Acc | 4.51 | 66M | — |
AQR Large Cap Defensive Style R6 | 3.83 | 56M | — |
iShares MSCI ACWI ETF | 3.35 | 49M | — |
iShares MSCI Global Min Vol Factor ETF | 3.33 | 49M | — |
Viking Global Equities Lp | 3.33 | 49M | — |
JPMorgan Prime Money Market Inst | 3.15 | 46M | Cash and Equivalents |